What is true IV ibogaine infusion?
True psychoactive IV ibogaine infusion means the ibogaine itself is administered intravenously under physician supervision in a medical infusion setting — consult → cardiac screening → monitored IV infusion → integration. It is not oral ibogaine (capsules, extract, or root bark) with an IV line used only for fluids, electrolytes, or supportive care.
Definition (canonical)
On this site, IV ibogaine infusion (also called intravenous ibogaine) is the psychoactive delivery of ibogaine by intravenous infusion under physician supervision. Continuous ECG/telemetry and emergency preparedness are non-negotiable because ibogaine can prolong the QTc interval.
Evidence gap (stated on purpose): Most published clinical literature — including Stanford-affiliated MISTIC / Cherian et al., Nature Medicine 2024 — describes oral ibogaine HCl, often with IV magnesium or other IV support for cardiac risk mitigation, not IV ibogaine as the psychoactive dose. Controlled evidence for psychoactive IV ibogaine remains sparse. Ibogaine is a U.S. Schedule I substance and is not FDA-approved for any indication.
The ketamine parallel — delivery route, not equivalence
Ketamine infusion clinics taught patients what an infusion visit feels like: screening, supervised IV delivery of a psychoactive medicine, observation, and follow-up. We borrow that journey shape for clarity — not scientific, legal, or risk equivalence. Pharmacology, evidence maturity, session length, and cardiac risk diverge sharply.
Psychoactive IV vs support IV
- True IV ibogaine infusion: psychoactive ibogaine delivered by vein under physician oversight with continuous telemetry
- Support IV only: oral ibogaine + IV fluids, magnesium, potassium, antiemetics, or emergency access — medically prudent in some settings, but still oral dosing
Accuracy rule: we position this brand entity as psychoactive IV infusion. We do not pretend that Cherian 2024, Knuijver 2021, or most observational OUD series were IV-psychoactive trials. Support IV ≠ psychoactive IV.
What a medical infusion setting should include
- Pre-qualification — substance-use history, psychiatric status, QT-prolonging meds, cardiac risk
- Diagnostics — ECG/EKG, electrolytes, liver/kidney as indicated
- Physician oversight during infusion and the peak-risk window
- Continuous cardiac monitoring (telemetry)
- Written documentation of psychoactive route (IV) plus any concurrent support IV
- Recovery observation measured in hours to days
- Integration / aftercare — psychosocial support after the acute session
Luxury rooms without items 2–5 are branding, not medical acuity. A nicer suite does not replace QTc risk management.
Evidence landscape (route-honest)
| Source type | Typical route | What it cannot prove |
|---|---|---|
| Open-label OUD / cardiac series (e.g. Knuijver 2021) | Oral ibogaine HCl | IV-ibogaine efficacy or safety equivalence |
| Veteran MISTIC (Cherian 2024) | Oral ibogaine + IV magnesium | That psychoactive IV ibogaine is validated |
| Systematic reviews | Mixed / predominantly non-IV psychoactive | Marketing “clinically proven IV” claims |
Legal snapshot (not legal advice)
- United States: Ibogaine is Schedule I (21 CFR 1308.11) and not FDA-approved for detoxification, depression, PTSD, or any other indication.
- Physician-supervised IV ibogaine infusion programs discussed on this site are provisionally available in Mexico. That is not FDA-approved U.S. clinic care. “Available abroad” ≠ approved medicine, uniform specialty regulation, or a guarantee of suitability or outcome. Not legal advice.
Related reading
- How it works — journey shape
- Safety & screening — cardiac non-negotiables
- Addiction · Depression · PTSD
- Blog keyword twin: What is IV ibogaine infusion?
Next step
Start with a confidential application
Screening comes before any treatment conversation — not after a sales pitch. Supervised IV ibogaine infusion inquiry is available provisionally in Mexico; not a U.S. FDA-approved clinic.